← Product Code [EMA](/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EMA) · K031467 # GLASIONOMER FX-II (K031467) _Shofu Dental Corp. · EMA · Jul 17, 2003 · Dental · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EMA/K031467 ## Device Facts - **Applicant:** Shofu Dental Corp. - **Product Code:** [EMA](/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EMA.md) - **Decision Date:** Jul 17, 2003 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 872.3275 - **Device Class:** Class 2 - **Review Panel:** Dental - **Attributes:** Therapeutic, Pediatric ## Indications for Use Glasionomer FX-II is a glass polyalkenoate cement used for dental restorations. Glasionomer FX-II is intended for use as a final restorative for deciduous teeth; a geriatric restorative for Class I, II, III and V cavities and cervical erosions; a final restorative for Class I and II of adult dentition in non-load bearing situations; an intermediate restorative for heavy stress cavities; a core build up; and for pit and fissure fillings. ## Device Story Glasionomer FX-II is a glass polyalkenoate dental cement. It is supplied as a powder and liquid kit, mixed by a dental professional using a spatula and pad. The material is applied to prepared tooth cavities or used for core build-ups. It functions as a restorative material for various cavity classes and deciduous teeth. The device is used in a clinical dental setting. It benefits patients by providing a restorative material for tooth decay and structural defects. ## Clinical Evidence Bench testing only. Biocompatibility testing performed including acute oral toxicity, bacterial reverse mutation, in vitro cytotoxicity, subcutaneous implantation, and sensitization. ## Technological Characteristics Glass polyalkenoate cement. Supplied as powder and liquid components. Manual mixing required. Biocompatible materials. ## Regulatory Identification Zinc oxide-eugenol is a device composed of zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp. Dental cement other than zinc oxide-eugenol is a device composed of various materials other than zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp. ## Predicate Devices - Fuji GP ([K961448](/device/K961448.md)) - Hy Bond Glasionomer CX ([K940122](/device/K940122.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows a sequence of handwritten characters and numbers. The sequence starts with the letters 'K' and 'O', followed by the numbers '3', '1', '4', '6', and '7'. The characters are written in a bold, slightly irregular style, giving them a distinct, hand-drawn appearance. # 510(k) Summary Shofu Dental Corporation Glasionomer FX-II | Submitted by: | Robert Noble, President
Shofu Dental Corporation
1225 Stone Drive
San Marcos, CA 92069-4059
(760)736-3277
FAX: (760)736-3276 | |----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------| | Company Contact: | Robert Noble, President | | Date Summary Prepared | May 2, 2003 | | Trade Name | Glasionomer FX-II | | Common Name | Dental Cement | | Classification | EMA | | Product Code | 872.3275(b) | | Substantially Equivalent Devices | Fuji GP [510(k) Number - K961448]
Hy Bond Glasionomer CX [510(k)
Number - K940122] | ### Description of Glasionomer FX-II Glasionomer FX-II is a glass polyalkenoate cement used for dental restorations, for Minimal Intervention (MI) dentistry. #### Intended Use: Glasionomer FX-II is a glass polyalkenoate cement used for dental restorations. Glasionomer FX-II is intended for use as a final restorative for deciduous teeth; a geriatric restorative for Class I, II, III and V cavities and cervical erosions; a final restorative for Class I and II of adult dentition in non-load bearing situations; an intermediate restorative for heavy stress cavities; a core build up; and for pit and fissure fillings. {1}------------------------------------------------ ## Components: . Glasionomer FX-II is available in two (2) different sets: The 1-1 Set contains the following and is available in four (4) shades: A2, A3, A3.5 and B2: - Powder 15g ● - Liquid 8ml (10g) ● - Spatula ● - Cocoa Butter 1g ● - Mixing Pad . - Matrix Strips ● - Powder Scoop ● - Instructions for Use ● The Mini Set contains the following and is available in the same four (4) shades: A2, A3, A3.5 and B2: - . Powder 6g - Liquid 2.8ml (3.5g) ● - Powder Scoop ● - Instructions for Use . Refills are available: single powder (15g) for all four (4) shades and a single liquid (8ml). #### Biocompatibility Glasionomer FX-II passed the following biocompatibility tests: - Acute oral toxicity . - Bacterial reverse mutation ● - In vitro cytotoxicity . - Subcutaneous implantation ● - Sensitization ● #### Conclusion The Glasionomer FX-II is substantially equivalent to Fuji GP powder 510(k) K961448 and Hy-Bond Glasionomer CX liquid 510(k) K940122. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles an abstract caduceus or a representation of the human form, with three wave-like lines emanating from it. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUL 17 2003 Mr. Robert Noble President Shofu Dental Corporation 1225 Stone Drive San Marcos, California 92069-4059 Re: K031467 Trade/Device Name: GlasIonomer FX-II Regulation Number: 21 CFR 872.3275(b) Regulation Name: Dental Cement Regulatory Class: II Product Codes: EMA Dated: May 02, 2003 Received: May 20, 2003 Dear Mr. Noble: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Mr. Robert Noble Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours. Susan Runner Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation ' Center for Devices and Radiological Health {4}------------------------------------------------ ## Indications for Use 510(k) Number (if known): Device Name: Glasionomer FX-II #### Indications For Use: Glasionomer FX-II is a glass polyalkenoate cement used for dental restorations. Glasionomer FX-II is intended for use as a final restorative for deciduous teeth; a geriatric restorative for Class I, II, III and V cavities and cervical erosions; a final restorative for Class I and II of adult dentition in non-load bearing situations; an intermediate restorative for heavy stress cavities; a core build up; and for pit and fissure fillings. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Keun Muly for KSN (Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices 510(k) Number: K031467 (Optional Format (3-10-98) Shofu Dental Corporation Glasionomer FX-II 510(k) Premarket Notification --- **Source:** [https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EMA/K031467](https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EMA/K031467) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com